ResearcherZhejiang Chinese Medical UniversityNo recent work listed
Hai Huang
Matched on ORCID iD 0000-0002-1811-9232; OpenAlex author ID A5076697932. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2014: 2 papers
Papers 2
- Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway. Last author DOI 10.3892/mmr.2014.2584↗
- Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. Co-author DOI 10.3892/or.2013.2888↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dian-Lei Liu · 2 shared papers, 2014 · strength 0.10
- Paper Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent… DOI 10.3892/mmr.2014.2584↗
- Paper Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. DOI 10.3892/or.2013.2888↗
- Heqi Bu · 2 shared papers, 2014 · strength 0.10
- Paper Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent… DOI 10.3892/mmr.2014.2584↗
- Paper Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. DOI 10.3892/or.2013.2888↗
- Junhui Cui · 1 shared paper, 2014 · strength 0.05
- Weitian Wei · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.